Cash from Financing (Quarterly) Chart

View Cash from Financing (Quarterly) for ERIE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Financing (Quarterly) Chart
Start Trial

Historical Cash from Financing (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 -54.70M
March 31, 2026 -80.42M
December 31, 2025 -55.96M
September 30, 2025 -44.40M
June 30, 2025 -41.12M
March 31, 2025 -58.38M
December 31, 2024 -59.77M
September 30, 2024 -57.82M
June 30, 2024 -53.03M
March 31, 2024 -59.38M
December 31, 2023 -55.42M
September 30, 2023 -55.42M
June 30, 2023 -55.42M
March 31, 2023 -55.42M
December 31, 2022 -51.69M
September 30, 2022 -91.69M
June 30, 2022 -105.24M
March 31, 2022 -52.22M
December 31, 2021 -48.72M
September 30, 2021 -48.71M
June 30, 2021 -48.71M
March 31, 2021 -48.70M
December 31, 2020 -138.58M
September 30, 2020 -45.43M
June 30, 2020 -45.44M
Date Value
March 31, 2020 -45.42M
December 31, 2019 -42.40M
September 30, 2019 -42.38M
June 30, 2019 -42.42M
March 31, 2019 -42.37M
December 31, 2018 -39.12M
September 30, 2018 -39.12M
June 30, 2018 -14.12M
March 31, 2018 -39.12M
December 31, 2017 -11.45M
September 30, 2017 -36.46M
June 30, 2017 -11.46M
March 31, 2017 -36.45M
December 31, 2016 -9.22M
September 30, 2016 -34.00M
June 30, 2016 -34.00M
March 31, 2016 -34.00M
December 31, 2015 -42.86M
September 30, 2015 -30.00M
June 30, 2015 -25.00M
March 31, 2015 -29.00M
December 31, 2014 -32.00M
September 30, 2014 -24.00M
June 30, 2014 -33.00M
March 31, 2014 -32.00M

Cash From Financing Definition

Represents the net cash flow resulting from the company's financing activities. Financing activities represent movement in the company's debt and share capital and other activities.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

View Cash from Financing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Financing (Quarterly) Benchmarks

View Cash from Financing (Quarterly) Benchmarks
Start Trial
Brown & Brown, Inc. -172.00M
Arthur J. Gallagher & Co. 1.251B
Ryan Specialty Holdings, Inc. 3.965M
Kingstone Cos., Inc. -1.398M
eHealth, Inc. -3.029M